Correction: Corrigendum: IAPP boosts islet macrophage IL-1 in type 2 diabetes

被引:0
|
作者
Thomas Mandrup-Poulsen
机构
关键词
D O I
10.1038/ni0311-271c
中图分类号
学科分类号
摘要
Nat. Immunol. 11, 881–883 (2010); published online 20 September 2010; corrected after print 21 October 2010. In the version of this article initially published, some of the text on p 882 was inaccurate. The correct text should read as follows: “thereby counteracting the beneficial effects of blocking IAPP on islet inflammation” (middle column) and “This mechanism has been suggested to mediate ROS-dependent inflammasome activation induced by high concentrations of glucose in mouse pancreatic beta cells12, although this finding is now being debated” (right column, first full paragraph, second sentence).
引用
收藏
页码:271 / 271
相关论文
共 50 条
  • [41] Serine Metabolism Supports Macrophage IL-1β Production
    Rodriguez, Arianne E.
    Ducker, Gregory S.
    Billingham, Leah K.
    Martinez, Carlos A.
    Mainolfi, Nello
    Suri, Vipin
    Friedman, Adam
    Manfredi, Mark G.
    Weinberg, Samuel E.
    Rabinowitz, Joshua D.
    Chandel, Navdeep S.
    CELL METABOLISM, 2019, 29 (04) : 1003 - +
  • [43] THE EFFECT OF CHITIN ON IL-1β PRODUCTION BY ALVEOLAR MACROPHAGE
    Katsura, Yoko
    Harada, Norihiro
    Harada, Sonoko
    Itoigawa, Yukinari
    Matsuno, Kei
    Ishimori, Ayako
    Makino, Fumihiko
    Ito, Jun
    Nagashima, Osamu
    Atsuta, Ryo
    Takahashi, Kazuhisa
    RESPIROLOGY, 2013, 18 : 97 - 97
  • [44] IL-1 ANTAGONISM FOR TREATMENT OF MACROPHAGE ACTIVATION SYNDROME
    Cron, Randy Q.
    Beukelman, Tim
    Bemrich-Stolz, Christy
    Watts, Raymond G.
    PEDIATRIC BLOOD & CANCER, 2011, 56 (04) : 701 - 701
  • [45] EFFECTS OF RETINOIDS ON MACROPHAGE FUNCTION AND IL-1 ACTIVITY
    DILLEHAY, DL
    WALIA, AS
    LAMON, EW
    JOURNAL OF LEUKOCYTE BIOLOGY, 1988, 44 (05) : 353 - 360
  • [46] IL-1 antagonism for treatment of macrophage activation syndrome
    Cron, Randy Q.
    Beukelman, Timothy
    Reed, Annelle B.
    Behrens, Edward M.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S247 - S248
  • [47] MACROPHAGE IL-1 AND MHC CONTROL IN ADJUVANT DISEASE
    SCHENKELAARS, EJ
    BONTA, IL
    FERRONE, S
    SINGH, HN
    QUAGLIATA, F
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1990, 32 (04) : 414 - 414
  • [48] Correction: Corrigendum: IL-1α is a DNA damage sensor linking genotoxic stress signaling to sterile inflammation and innate immunity
    Idan Cohen
    Peleg Rider
    Elena Vornov
    Martin Tomas
    Cicerone Tudor
    Mareike Wegner
    Lydia Brondani
    Marina Freudenberg
    Gerhard Mittler
    Elisa Ferrando-May
    Charles A. Dinarello
    Ron N. Apte
    Robert Schneider
    Scientific Reports, 6
  • [49] RETRACTION: Emerging insights into the role of IL-1 inhibitors and colchicine for inflammation control in type 2 diabetes
    Guan, Jianbin
    Abudouaini, Haimiti
    Lin, Kaiyuan
    Yang, Kaitan
    DIABETOLOGY & METABOLIC SYNDROME, 2025, 17 (01):
  • [50] IL-1β Exacerbates Amyloid Deposition In Islets: A Mechanism for Increased β-Cell Loss in Type 2 Diabetes?
    Mellati, Mahnaz
    Meier, Daniel
    Hogan, Meghan F.
    Templin, Andrew T.
    Kahn, Steven E.
    DIABETES, 2016, 65 : A535 - A535